Egg Consumption and Mortality Due to Cardiovascular Events

According to this study recently published in prestigious journal JAMA, eating too much cholesterol or eggs (which have a high concentration of it in the yolk) is significantly associated with a higher risk of cardiovascular events and all-cause mortality, with a typical dose/effect curve. According to the authors, this information should be considered for an update of current dietary guidelines.

colesterol ldl placas coronarias

Cholesterol is a common nutrient in any non-vegan diet and eggs are its main source. Recommendations on egg consumption have seen many different stages: from regarding it as “public enemy #1” to encouraging its consumption. This work seeks to put an end to controversy and deliver definitive information.

This analysis included 29,615 participants with a mean age of about 50 years old and a mean follow-up of 17.5 years.

For each additional 300 mg of dietary cholesterol consumed per day (very hard to measure in daily practice) or each additional half an egg per day (much easier to measure), there was a significant increase in cardiovascular events (adjusted hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.09 to 1.26) and all-cause mortality (adjusted HR: 1.18; 95% CI: 1.10 to 1.26).


Read also: Strict LDL Monitoring Helps Reduce Plaque Volume.


The association between egg consumption and cardiovascular events or all-cause death was no longer significant after adjusting for dietary cholesterol consumption. This might mean that the problem lies in cholesterol itself, and that eggs are simply an easy way to measure it. There might not be any additional deleterious component (other than cholesterol) in eggs. Reducing egg consumption ultimately reduces cholesterol consumption.

Original Title: Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality.

Reference: Victor W. Zhong et al. JAMA. 2019;321(11):1081-1095.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR and Anticoagulation: What Should We Do?

Transcatheter aortic valve replacement (TAVR) has consolidated as a valid strategy for certain groups of patients. However, approximately one third of those who require...

Direct Oral Anticoagulants for Ventricular Thrombus After STEMI

While the incidence of intracavitary thrombi after acute myocardial infarction (AMI) has decreased thanks to optimized primary angioplasty times, some studies report rates of...

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...